➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Merck
Colorcon
AstraZeneca
Dow

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Boehringer Ingelheim Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patents for Boehringer Ingelheim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Boehringer Ingelheim CYLTEZO adalimumab-adbm INJECTABLE;INJECTION 761058 001 2017-08-25 RX
Boehringer Ingelheim PRAXBIND idarucizumab INJECTABLE;INJECTION 761025 001 2015-10-16 10,703,800 LA JOLLA BIOLOGICS, INC. (San Diego, CA) 2036-04-26 RX Orphan search
Boehringer Ingelheim PRAXBIND idarucizumab INJECTABLE;INJECTION 761025 001 2015-10-16 10,590,182 The Regents of the University of California (Oakland, CA) 2035-02-24 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Dow
McKinsey
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.